Meta-analysis of Associations Between the Peroxisome Proliferator-activated Receptor-γ Pro12Ala Polymorphism and Susceptibility to Nonalcoholic Fatty Liver Disease, Rheumatoid Arthritis, and Psoriatic Arthritis

Overview

Journal Genet Test Mol Biomarkers

Specialties Genetics
Molecular Biology

Date 2014 Apr 5

PMID 24697566

Citations 14

Authors

Young Ho Lee

Sang-Cheol Bae

Gwan Gyu Song

Affiliations

Soon will be listed here.

Abstract

Introduction: The purpose of this study was to examine whether a Proline (Pro)-to-Alanine (Ala) exchange at codon 12 (Pro12Ala) polymorphism of the peroxisome proliferator-activated receptor-gamma (PPARγ) is associated with susceptibility to nonalcoholic fatty liver disease (NAFLD), rheumatoid arthritis (RA), and psoriatic arthritis (PsA).

Methods: A meta-analysis was conducted on the association between the PPARγ Pro12Ala polymorphism and NAFLD, RA, and PsA.

Results: Nine studies, including five on NAFLD, two on RA, and two on PsA, were available for the meta-analysis consisting of 8082 cases and 3790 controls. The meta-analysis revealed no association between the Ala allele of the PPARγ Pro12Ala polymorphism and NAFLD (odds ratios [OR]=0.936, 95% confidence interval [CI]=0.672-1.302, p=0.693). However, stratification by ethnicity indicated an association between the Ala allele and NAFLD in East Asians (OR=0.700, 95% CI=0.496-0.987, p=0.042), but not in Europeans (OR=1.128, 95% CI=0.863-1.475, p=0.378). Analysis using the dominant model showed the same Ala allele pattern in East Asians and Europeans (OR=0.688, 95% CI=0.484-0.978, p=0.037; OR=1.051, 95% CI=0.782-1.413, p=0.742), demonstrating a significant association between the Ala allele and NAFLD in East Asians. The meta-analysis revealed no association between the Ala allele and RA in East Asians (OR=0.467, 95% CI=0.188-1.161, p=0.101), and no association was found between the Ala allele and PsA in Europeans (OR=0.869, 95% CI=0.465-1.627, p=0.662).

Conclusions: Our meta-analysis demonstrates that the PPARγ Pro12Ala polymorphism is associated with susceptibility to NAFLD in East Asians, but not in European populations.

Citing Articles

Identification and Experimental Verification of PDK4 as a Potential Biomarker for Diagnosis and Treatment in Rheumatoid Arthritis.

Zheng X, Huang J, Meng J, Wang H, Chen L, Yao J Mol Biotechnol. 2024; .

PMID: 39466354 DOI: 10.1007/s12033-024-01297-1.

Association of adipocytokine pathway gene polymorphisms with NAFLD in obese children.

Wang J, Pan X, Wei J, Li X, Zhou H, Xu N Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024; 49(5):775-783.

PMID: 39174891 PMC: 11341219. DOI: 10.11817/j.issn.1672-7347.2024.230098.

Nutrigenetic Interaction Between Apolipoprotein C3 Polymorphism and Fat Intake in People with Nonalcoholic Fatty Liver Disease.

Yamamoto R, Takeshita Y, Tsujiguchi H, Kannon T, Sato T, Hosomichi K Curr Dev Nutr. 2023; 7(4):100051.

PMID: 37304843 PMC: 10257212. DOI: 10.1016/j.cdnut.2023.100051.

Peroxisome Proliferator-Activated Receptor-γ as a Target and Regulator of Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease.

Zaiou M Cells. 2023; 12(8).

PMID: 37190114 PMC: 10136748. DOI: 10.3390/cells12081205.

Molecular Dynamics Simulation and Essential Dynamics of Deleterious Proline 12 Alanine Single-Nucleotide Polymorphism in PPAR2 Associated with Type 2 Diabetes, Cardiovascular Disease, and Nonalcoholic Fatty Liver Disease.

Taghvaei S, Saremi L PPAR Res. 2022; 2022:3833668.

PMID: 35547362 PMC: 9085344. DOI: 10.1155/2022/3833668.

References

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

Hui Y, Yu-Yuan L, Yu-Qiang N, Wei-Hong S, Yan-Lei D, Xiao-Bo L . Effect of peroxisome proliferator-activated receptors-gamma and co-activator-1alpha genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people. Liver Int. 2007; 28(3):385-92. DOI: 10.1111/j.1478-3231.2007.01623.x. View

Choi S, Rho Y, Ji J, Song G, Lee Y . Genome scan meta-analysis of rheumatoid arthritis. Rheumatology (Oxford). 2005; 45(2):166-70. DOI: 10.1093/rheumatology/kei128. View

Yang Z, Wen J, Li Q, Tao X, Ye Z, He M . PPARG gene Pro12Ala variant contributes to the development of non-alcoholic fatty liver in middle-aged and older Chinese population. Mol Cell Endocrinol. 2011; 348(1):255-9. DOI: 10.1016/j.mce.2011.09.001. View

Gavrilova O, Haluzik M, Matsusue K, Cutson J, Johnson L, Dietz K . Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem. 2003; 278(36):34268-76. DOI: 10.1074/jbc.M300043200. View

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

Jalil S, Ahmed I, Gauhar Z, Ahmed M, Malik J, John P . Association of Pro12Ala (rs1801282) variant of PPAR gamma with rheumatoid arthritis in a Pakistani population. Rheumatol Int. 2013; 34(5):699-703. DOI: 10.1007/s00296-013-2768-2. View

Gupta A, Chaudhory A, Sukriti , Pande C, Sakhuja P, Singh Y . Peroxisome proliferators-activated receptor γ2 Pro12Ala variant is associated with body mass index in non-alcoholic fatty liver disease patients. Hepatol Int. 2011; 5(1):575-80. PMC: 3034001. DOI: 10.1007/s12072-010-9225-z. View

10.

Butt C, Gladman D, Rahman P . PPAR-gamma gene polymorphisms and psoriatic arthritis. J Rheumatol. 2006; 33(8):1631-3. View

11.

Zhou Y, Li Y, Nie Y, Yang H, Zhan Q, Huang J . Influence of polygenetic polymorphisms on the susceptibility to non-alcoholic fatty liver disease of Chinese people. J Gastroenterol Hepatol. 2010; 25(4):772-7. DOI: 10.1111/j.1440-1746.2009.06144.x. View

12.

Terauchi Y . [PPARgamma and metabolic syndrome]. Rinsho Byori. 2007; 55(5):447-51. View

13.

Pan X, Song X, Wang L, Li L, Ying B . [Association of the Pro12Ala polymorphism in peroxisome proliferators activated receptor-gamma gene with rheumatoid arthritis in Sichuan Province of China]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009; 26(1):87-90. DOI: 10.3760/cma.j.issn.1003-9406.2009.01.020. View

14.

Thamer C, Haap M, Volk A, Maerker E, Becker R, Bachmann O . Evidence for greater oxidative substrate flexibility in male carriers of the Pro 12 Ala polymorphism in PPARgamma2. Horm Metab Res. 2002; 34(3):132-6. DOI: 10.1055/s-2002-23196. View

15.

Egger M, Smith G, Phillips A . Meta-analysis: principles and procedures. BMJ. 1998; 315(7121):1533-7. PMC: 2127925. DOI: 10.1136/bmj.315.7121.1533. View

16.

Gawrieh S, Marion M, Komorowski R, Wallace J, Charlton M, Kissebah A . Genetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with histologically advanced NAFLD. Dig Dis Sci. 2011; 57(4):952-7. DOI: 10.1007/s10620-011-1994-2. View

17.

Bhatt S, Nigam P, Misra A, Guleria R, Luthra K, Pandey R . Association of peroxisome proliferator activated receptor-γ gene with non-alcoholic fatty liver disease in Asian Indians residing in north India. Gene. 2012; 512(1):143-7. DOI: 10.1016/j.gene.2012.09.067. View

18.

Luo W, Cao J, Li J, He W . Adipose tissue-specific PPARgamma deficiency increases resistance to oxidative stress. Exp Gerontol. 2007; 43(3):154-63. DOI: 10.1016/j.exger.2007.11.002. View

19.

Lee Y, Rho Y, Choi S, Ji J, Song G . Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis. Rheumatol Int. 2006; 27(2):157-61. DOI: 10.1007/s00296-006-0175-7. View

20.

Dimitrova-Shumkovska J, Veenman L, Ristoski T, Leschiner S, Gavish M . Chronic high fat, high cholesterol supplementation decreases 18 kDa Translocator Protein binding capacity in association with increased oxidative stress in rat liver and aorta. Food Chem Toxicol. 2010; 48(3):910-21. DOI: 10.1016/j.fct.2009.12.032. View